AstraZeneca's COVID-19 Vaccine Demonstrates 92% Efficacy Against Delta (Indian) Variant
Shots:
- Real world data from PHE demonstrated two doses of AZ’s vaccine are 92% effective against hospitalization due to the Delta variant and showed no deaths among the vaccinated
- The vaccine was highly effective against the Alpha variant (kent variant) with an 86% reduction of hospitalizations and no reported deaths. Vaccine effectiveness against the symptomatic disease was 74% against the Alpha variant and 64% against the Delta variant
- The RWE against the Delta variant is based on limited follow up after the second dose impacting the effectiveness estimate
| Ref: AstraZeneca | Image: Business Standard
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com